参考文献/References:
[1] CHUNG J M,HA H K,KIM D H,et al.Evaluation of the efficacy of solifenacin for preventing catheter-related bladder discomfort after transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer:A prospective,randomized,multicenter study[J].Clin Genitourin Cancer,2017,15(1):157-162.
[2] ZHANG Z,CAO Z,XU C,et al.Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors[J].Urology,2014,84(1):117-121.
[3] WANG J P,ZHOU Z B,CUI Y S,et al.Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder[J].Neurourol Urodyn,2019,38(1):22-30.
[4] GRATZKE C,VAN MAANEN R,CHAPPLE C,et al.Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder:A randomised,multicentre phase 3 study(SYNERGY Ⅱ)[J].Eur Urol,2018,74(4):501-509.
[5] KELLEHER C,HAKIMI Z,ZUR R,et al. Efficacy and tolerability of mirabegron compared with antimuscarinic mono-therapy or combination therapies for overactive bladder:A systematic review and network Meta-analysis[J].Eur Urol,2018,74(3):324-333.
[6] YAMANISHI T,CHAPPLE C R,CHESS-WILLIAMS R.
Which muscarinic receptor is important in the bladder?[J].World J Urol,2001,19(5):299-306.
[7] REN J,YU T,TIAN Y,et al.Comparative effectiveness of interventions for managing urological postoperative catheter-related bladder discomfort:a systematic review and network meta-analysis[J].BMC Urol,2023,23(1):29.
[8] LI S,LI P,WANG R,et al.Different interventions for preventing postoperative catheter-related bladder discomfort:a systematic review and meta-analysis[J].Eur J Clin Pharmacol,2022,78(6):897-906.
[9] JANG E B,HONG S H,KIM K S,et al.Catheter-related bladder discomfort:how can we manage it?[J].Int Neurourol J,2020,24(4):324-331.
[10] AGARWAL A,DHIRAAJ S,SINGHAL V,et al.Compa-rison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort:a prospective,randomized,placebo-controlled,double-blind study[J].Br J Anaesth,2006,96(3):377-380.
[11] PENG X F,LV X G,XIE H,et al.Effectiveness of solifenacin for managing of bladder spasms in patients with urethroplasty[J].Am J Mens Health,2017,11(5):1580-1587.
[12] IN C B,LEE S J,SUNG T Y,et al.Effects of chlorpheniramine maleate on catheter-related bladder discomfort in patients undergoing ureteroscopic stone removal:a randomized double-blind study[J].Int J Med Sci,2021,18(4):1075-1081.
[13] SRIVASTAVA V K,AGRAWAL S,KADIYALA V N,et al.The efficacy of pregabalin for prevention of catheter-related bladder discomfort:a prospective,randomized,placebo-controlled double-blind study[J].J Anesth,2015,29(2):212-216.
[14] CHEON Y W,KIM S H,PAEK J H,et al.Effects of nefopam on catheter-related bladder discomfort in patients undergoing ureteroscopic litholapaxy[J].Korean J Anesthesiol,2018,71(3):201-206.
[15] LI S Y,LI H,NI J,et al.Comparison of intravenous lidocaine and dexmedetomidine infusion for prevention of postoperative catheter-related bladder discomfort:a randomized controlled trial[J].BMC Anesthesiol,2019,19(1):37.
[16] KENNELLY M J,RHODES T,GIRMAN C J,et al.efficacy of vibegron and mirabegron for overactive bladder:a systematic literature review and indirect treatment comparison [J].Adv Ther,2021,38(11):5452-5464.
[17] DEEKS E D.MIRABEGRON:a review in overactive bladder syndrome[J].Drugs,2018,78(8):833-844.
[18] FAN B,SHEN J,WU L,et al.Study of mirabegron and solifenacin in the improvement of catheter-related bladder discomfort in patients undergoing transurethral resection:a case-control study[J].Medicine(Baltimore),2022,101(48):e32052.
[19] 陈铁定,王荫槐,杨罗艳,等.间苯三酚预防前列腺电切术后膀胱痉挛的疗效分析[J].中华男科学杂志,2010,16(11):1004-1006.
[20] MUELLER E R,VAN MAANEN R,CHAPPLE C,et al.Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin:a prespecified analysis from the randomized,phase Ⅲ SYNERGY Ⅱ study[J].Neurourol Urodyn,2019,38(2):779-792.